Invokana Linked to Kidney Damage, Diabetic Ketoacidosis

Written By:
Jessie Paluch
Jessie Paluch

Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.

TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.

Invokana Linked to Kidney Damage, Diabetic Ketoacidosis

Invokana was introduced to the U.S. market in March 2013 and quickly became the go-to type 2 diabetes treatment, although the safety of the medication became a point of contention relatively quickly.

invokana ketoacidosis linked
Table of Contents

What is Invokana?

Invokana is a SGLT2 inhibitor that is prescribed along with diet and exercise to help improve glycemic control and lower blood sugar in adult patients with type 2 diabetes mellitus.

If left untreated, type 2 diabetes can lead to a number of serious health problems, including:

  • Blindness
  • Nerve damage
  • Kidney failure
  • Heart disease
  • Stroke
  • High blood pressure

In May 2015, the FDA warned the public that canagliflozin (Invokana), dapagliflozin (Farxiga), and empagliflozin (Jardiance) may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization and could lead to death.

The FDA warned patients to pay close attention for signs of Ketoacidosis and to seek medical attention if they experienced any signs.

Symptoms of Diabetic Ketoacidosis Include

  • Difficulty Breathing
  • Nausea
  • Vomiting
  • Abdominal Pain
  • Confusion
  • Unusual Fatigue
  • Sleepiness

Following the warning issued in May 2015, the FDA reviewed the FDA Adverse Event Reporting System and identified 73 cases of ketoacidosis in patients with type 1 or type 2 diabetes.

As a result, the FDA followed up with a label change for Invokana, Farxiga and Jardiance in December 2015 which noted the risk of ketoacidosis.

In addition to diabetic ketoacidosis, there are several other serious and even potentially fatal side effects associated with Invokana, Farxiga and Jardiance, including:

  • Myocardial infarction (heart attack) – the irreversible death of cells within the heart caused by a restriction of blood.
  • Kidney damage and failure – the kidneys stop functioning properly or at all, and waste products, fluids, and electrolytes build up in the body, causing weakness, shortness or breath, lethargy, confusion, abnormal heart rhythm, and sudden death.

Concerns About Safety of Invokana Continue to be Raised

In January 2016, the Institute for Safe Medication Practices released a report that highlighted potential concerns regarding a link between Invokana and kidney damage.

According to the report, both prescription volume and adverse drug event reports are increasing rapidly for canagliflozin (Invokana), dapagliflozin (Farxiga), and empagliflozin (Jardiance).

Diabetic Ketoacidosis Lawsuits Move Forward

Lawsuits on behalf of individuals diagnosed with diabetic ketoacidosis continue to be filed against the manufacturers of the drugs, Janssen Pharmaceuticals, AstraZeneca and Boehringer Ingelheim.

Plaintiffs allege that they were not warned of the serious risk involved with taking Invokana, Farxiga or Jardiance.

Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources